X, F., S, J., Y, L., Y, G., B, G., J, L., . . . L, Y. (2025). Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors. Journal of Hepatocellular Carcinoma, ume 12(Issue 1), 1069-1082.
Chicago Style (17th ed.) CitationX, Fu, et al. "Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors." Journal of Hepatocellular Carcinoma ume 12, no. Issue 1 (2025): 1069-1082.
MLA (9th ed.) CitationX, Fu, et al. "Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors." Journal of Hepatocellular Carcinoma, vol. ume 12, no. Issue 1, 2025, pp. 1069-1082.
Warning: These citations may not always be 100% accurate.
